samedi 7 septembre 2019

CRISPR: the EU has no ambition and a lot of brakes

Our medical research capacities are not turned toward the future. Regulations, precautionary principle, vilifying genetic scientific research, lack of space for disruptive research in our academic world, obstruction of new candidates by the crony careerism in national agencies are among the main causes...

Martin-Laffon, J., Kuntz, M., & Ricroch, A. E. (2019). Worldwide CRISPR patent landscape shows strong geographical biases. Nature Biotechnology, 37(6), 613–620. doi:10.1038/s41587-019-0138-7 

Unleash innovation to spur growth in Europe

Is it only bla bla?
https://ec.europa.eu/docsroom/documents/35892
à

Aucun commentaire:

Enregistrer un commentaire